138 related articles for article (PubMed ID: 38777603)
1. Evaluation of Systemic and Brain Pharmacokinetic Parameters for Repurposing Metformin Using Intravenous Bolus Administration.
Sharma S; Zhang Y; Patel D; Akter KA; Bagchi S; Sifat AE; Nozohouri E; Ahn Y; Karamyan VT; Bickel U; Abbruscato TJ
J Pharmacol Exp Ther; 2024 May; ():. PubMed ID: 38777603
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic-Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes.
Tee KB; Ibrahim L; Hashim NM; Saiman MZ; Zakaria ZH; Huri HZ
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745841
[TBL] [Abstract][Full Text] [Related]
3. Use of Intravenous Infusion Study Design to Simultaneously Determine Brain Penetration and Systemic Pharmacokinetic Parameters in Rats.
Noh K; Pietrasiewicz A; Liu X; Wei C
Drug Metab Dispos; 2021 Feb; 49(2):142-151. PubMed ID: 33262223
[TBL] [Abstract][Full Text] [Related]
4. Permeability of Metformin across an In Vitro Blood-Brain Barrier Model during Normoxia and Oxygen-Glucose Deprivation Conditions: Role of Organic Cation Transporters (Octs).
Sharma S; Zhang Y; Akter KA; Nozohouri S; Archie SR; Patel D; Villalba H; Abbruscato T
Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242599
[TBL] [Abstract][Full Text] [Related]
5. Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke.
Sharma S; Nozohouri S; Vaidya B; Abbruscato T
Life Sci; 2021 Jun; 274():119343. PubMed ID: 33716063
[TBL] [Abstract][Full Text] [Related]
6. Quantitative investigation of the brain-to-cerebrospinal fluid unbound drug concentration ratio under steady-state conditions in rats using a pharmacokinetic model and scaling factors for active efflux transporters.
Kodaira H; Kusuhara H; Fuse E; Ushiki J; Sugiyama Y
Drug Metab Dispos; 2014 Jun; 42(6):983-9. PubMed ID: 24644297
[TBL] [Abstract][Full Text] [Related]
7. Translational CNS Steady-State Drug Disposition Model in Rats, Monkeys, and Humans for Quantitative Prediction of Brain-to-Plasma and Cerebrospinal Fluid-to-Plasma Unbound Concentration Ratios.
Sato S; Matsumiya K; Tohyama K; Kosugi Y
AAPS J; 2021 Jun; 23(4):81. PubMed ID: 34085128
[TBL] [Abstract][Full Text] [Related]
8. Metformin's Intrinsic Blood-to-Plasma Partition Ratio (B/P): Reconciling the Perceived High In Vivo B/P > 10 with the In Vitro Equilibrium Value of Unity.
Xie F; Ke AB; Bowers GD; Zamek-Gliszczynski MJ
J Pharmacol Exp Ther; 2015 Aug; 354(2):225-9. PubMed ID: 26062557
[TBL] [Abstract][Full Text] [Related]
9. A non-linear pharmacokinetic-pharmacodynamic relationship of metformin in healthy volunteers: An open-label, parallel group, randomized clinical study.
Chung H; Oh J; Yoon SH; Yu KS; Cho JY; Chung JY
PLoS One; 2018; 13(1):e0191258. PubMed ID: 29342199
[TBL] [Abstract][Full Text] [Related]
10. Ablation of both organic cation transporter (OCT)1 and OCT2 alters metformin pharmacokinetics but has no effect on tissue drug exposure and pharmacodynamics.
Higgins JW; Bedwell DW; Zamek-Gliszczynski MJ
Drug Metab Dispos; 2012 Jun; 40(6):1170-7. PubMed ID: 22407892
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic in vitro studies confirm that inhibition of the renal apical efflux transporter multidrug and toxin extrusion (MATE) 1, and not altered absorption, underlies the increased metformin exposure observed in clinical interactions with cimetidine, trimethoprim or pyrimethamine.
Elsby R; Chidlaw S; Outteridge S; Pickering S; Radcliffe A; Sullivan R; Jones H; Butler P
Pharmacol Res Perspect; 2017 Oct; 5(5):. PubMed ID: 28971610
[TBL] [Abstract][Full Text] [Related]
12. γ-Hydroxybutyric Acid (GHB) Pharmacokinetics and Pharmacodynamics: Semi-Mechanistic and Physiologically Relevant PK/PD Model.
Dave RA; Follman KE; Morris ME
AAPS J; 2017 Sep; 19(5):1449-1460. PubMed ID: 28653244
[TBL] [Abstract][Full Text] [Related]
13. Unbound Brain-to-Plasma Partition Coefficient, K
Loryan I; Reichel A; Feng B; Bundgaard C; Shaffer C; Kalvass C; Bednarczyk D; Morrison D; Lesuisse D; Hoppe E; Terstappen GC; Fischer H; Di L; Colclough N; Summerfield S; Buckley ST; Maurer TS; Fridén M
Pharm Res; 2022 Jul; 39(7):1321-1341. PubMed ID: 35411506
[TBL] [Abstract][Full Text] [Related]
14. Targeting BCAA metabolism to potentiate metformin's therapeutic efficacy in the treatment of diabetes in mice.
Zhao X; Zhang X; Pei J; Liu Y; Niu W; Sun H
Diabetologia; 2023 Nov; 66(11):2139-2153. PubMed ID: 37581618
[TBL] [Abstract][Full Text] [Related]
15. Safety, Tolerability, Pharmacokinetics and Quantitative Electroencephalography Assessment of ACD856, a Novel Positive Allosteric Modulator of Trk-Receptors Following Multiple Doses in Healthy Subjects.
Önnestam K; Nilsson B; Rother M; Rein-Hedin E; Bylund J; Anderer P; Kemethofer M; Halldin MM; Sandin J; Segerdahl M
J Prev Alzheimers Dis; 2023; 10(4):778-789. PubMed ID: 37874100
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of single rising intravenous doses (0.5 mg-10 mg) and determination of absolute bioavailability of the dipeptidyl peptidase-4 inhibitor linagliptin (BI 1356) in healthy male subjects.
Retlich S; Duval V; Ring A; Staab A; Hüttner S; Jungnik A; Jaehde U; Dugi KA; Graefe-Mody U
Clin Pharmacokinet; 2010 Dec; 49(12):829-40. PubMed ID: 21053992
[TBL] [Abstract][Full Text] [Related]
17. Significant impact of time-of-day variation on metformin pharmacokinetics.
Türk D; Scherer N; Selzer D; Dings C; Hanke N; Dallmann R; Schwab M; Timmins P; Nock V; Lehr T
Diabetologia; 2023 Jun; 66(6):1024-1034. PubMed ID: 36930251
[TBL] [Abstract][Full Text] [Related]
18. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
Singh SS
Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
[TBL] [Abstract][Full Text] [Related]
19. Development of a population pharmacokinetic model to predict brain distribution and dopamine D2 receptor occupancy of raclopride in non-anesthetized rat.
Wong YC; Ilkova T; van Wijk RC; Hartman R; de Lange ECM
Eur J Pharm Sci; 2018 Jan; 111():514-525. PubMed ID: 29106979
[TBL] [Abstract][Full Text] [Related]
20. Meta-Assessment of Metformin Absorption and Disposition Pharmacokinetics in Nine Species.
Jeong YS; Jusko WJ
Pharmaceuticals (Basel); 2021 Jun; 14(6):. PubMed ID: 34200427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
